Guggenheim analyst Michael Schmidt lowered the firm’s price target on SpringWorks Therapeutics (SWTX) to $78 from $80 and ...
Third-grade students at Guggenheim Elementary School were given a unique cultural experience on Jan. 3 when guest presenter ...
As previously reported, Guggenheim analyst John DiFucci upgraded Workday (WDAY) to Neutral from Sell with no price target While the firm still ...
Agentforce was launched in September and already signed up 200 companies to deploy Agentforce as their smarter chatbot. Marc ...
With its stunning Frank Lloyd Wright design, the Guggenheim Museum is a piece of art in itself. Inside these rounded walls, you’ll find floor upon floor of artistic treasures. The modern and ...
Guggenheim downgraded Palo Alto Networks (PANW) to Sell from Neutral with a $130 price target Stay Ahead of the Market:Discover outperforming ...
The exhibition spotlights a contradictory modern art movement that, though it celebrated technological advances, was rooted ...
MongoDB stock was higher early Monday after analysts at Guggenheim upgraded their view on the company to a buy rating.
Guggenheim has expanded its risk-management capabilities significantly in recent ‎‎years, though, and valuation-driven cutting of risk in 2018 and 2019—despite putting the strategy ...